Invesco Ltd. Buys 750,046 Shares of Agilon Health, Inc. $AGL

Key Points

• Invesco Ltd. increased its holdings in Agilon Health by 186.7% during the 1st quarter, owning approximately 1.15 million shares valued at $4.99 million.
• Agilon Health's stock has experienced a 1-year range of $0.71 to $6.08, closing at $1.31, while the company reported a loss of $0.25 EPS, missing estimates.
• Analysts have downgraded Agilon Health's price targets, with a consensus rating of "Hold" and an average price target of $3.07 amidst various new institutional investments.

Invesco Ltd. increased its position in Agilon Health, Inc. (NYSE:AGL - Free Report) by 186.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,151,795 shares of the company's stock after buying an additional 750,046 shares during the period. Invesco Ltd. owned 0.28% of Agilon Health worth $4,987,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC increased its holdings in Agilon Health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after buying an additional 6,783 shares during the last quarter. Ridgecrest Wealth Partners LLC acquired a new position in Agilon Health in the first quarter worth approximately $65,000. Pallas Capital Advisors LLC acquired a new position in Agilon Health in the first quarter worth approximately $66,000. Humankind Investments LLC acquired a new position in Agilon Health in the fourth quarter worth approximately $30,000. Finally, KBC Group NV acquired a new position in Agilon Health in the first quarter worth approximately $70,000.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. The Goldman Sachs Group increased their price objective on Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. Jefferies Financial Group lowered their price target on Agilon Health from $2.40 to $1.10 and set a "hold" rating on the stock in a report on Friday, August 15th. Sanford C. Bernstein reiterated a "market perform" rating and set a $1.40 price target (down previously from $4.00) on shares of Agilon Health in a report on Wednesday, August 20th. Evercore ISI lowered their price target on Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a report on Wednesday, July 9th. Finally, Barclays lowered their price target on Agilon Health from $3.00 to $1.50 and set an "underweight" rating on the stock in a report on Wednesday, August 6th. Four investment analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Agilon Health has an average rating of "Hold" and an average price target of $3.07.

Agilon Health Price Performance

Shares of AGL traded down $0.01 during trading hours on Tuesday, hitting $1.28. The stock had a trading volume of 4,051,583 shares, compared to its average volume of 22,805,340. Agilon Health, Inc. has a 52 week low of $0.71 and a 52 week high of $6.08. The stock has a market capitalization of $528.39 million, a price-to-earnings ratio of -1.66 and a beta of 0.11. The company's fifty day moving average is $1.74 and its two-hundred day moving average is $2.88.

Agilon Health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The firm had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.Agilon Health's revenue for the quarter was down 5.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.07) earnings per share. Equities analysts predict that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.